Dainippon Sumitomo Pharma America Inc. Announces FDA Acceptance of Lurasidone New Drug Application for Treatment of Schizophrenia
More...
|
InterMune, Inc. (ITMN) Announces Conference Call and Webcast to Discuss Outcome of FDA Advisory Committee
More...
|
Advanced Life Sciences Holdings, Inc. (ADLS) Sciences Receives FDA Guidance on Approval Pathway for Restanza in Community Acquired Bacterial Pneumonia and Biodefense Indications
More...
|
Neoprobe Corporation (NEOP) to Hold Lymphoseek Update Call
More...
|
Generex Biotechnology Corporation (GNBT) Receives Positive Responses From Independent Physicians and Nurse Practitioners in Recent Focus Groups Conducted in the United States for Generex Oral-lyn(TM)
More...
|
ProFibrix Reports Phase II Results of Hemostasis Product Fibrocaps(TM) and Appoints New Chief Medical Officer
More...
|
CBio Limited Secures Another Clinical Trial Milestone
More...
|
Stem Cell Therapeutics (SSS.V) Announces Publication of Phase IIa Stroke Data
More...
|
FDA Grants Bayer HealthCare Pharmaceuticals (BAY) Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis
More...
|
Allon Therapeutics, Inc.'s Phase 1 Trial Broadens Davunetide's Intranasal Safety and Dose Range
More...
|
PolyMedix Inc. Presents PMX-30063 Antibiotic Data at 8th World Congress on Trauma, Shock, Inflammation and Sepsis – TSIS 2010
More...
|
Emerging Healthcare Solutions, Inc. (EHSI) New High-Level Telemedicine Study Launched
More...
|
Life Technologies AG Release: Scientists Discover Causative Genetic Mutation Associated with Common Inherited Neurological Disorder
More...
|
Proximagen Neuroscience plc (PRX.L) Announces Positive Efficacy Results In National Institutes of Health (NIH) Epilepsy Studies
More...
|
The New England Journal of Medicine Publishes Clinical Results On Karo Bio AB's
More...
|
Advaxis, Inc. Develops Room Temperature Formulation of ADXS11-001
More...
|